Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Pharmaceutical
The share price of US drugmaker AbbVie was in decline again on Monday morning after revenue levels in its third quarter results fell below analysts’ predictions. 31 October 2016
Pharmaceutical
US healthcare giant Johnson & Johnson reported sales of $17.8 billion for the third quarter of 2016, a 4.2% increase compared to the same period last year. 18 October 2016
Pharmaceutical
Swiss pharma giant Novartis is to close two research units and cut around 175 jobs as part of a new research strategy. 6 October 2016
Pharmaceutical
Around 1,000 jobs are to go at Danish diabetes giant Novo Nordisk, which amounts to nearly 2.4% of its total global workforce.
This action has been described in a statement as “one of several actions taken to reduce operating costs as the company faces a challenging competitive environment in 2017, especially in its large US market.” 29 September 2016
Pharmaceutical
Pfizer has ended speculation that it is to split by announcing that it will remain one company. 26 September 2016
Pharmaceutical
Werner Baumann, management board chairman at German pharma and crop sciences major Bayer, is confident that the company can deliver after raising the combined peak annual sales potential of five recently launched pharmaceutical products by a third. 20 September 2016
Pharmaceutical
In our weekly expert view piece, Michael Jewell, healthcare partner at Cavendish Corporate Finance, explains why we can expect mid-market companies to press on with their expansion through strategic transactions for the remainder of 2016. 20 September 2016
Biotechnology
Belgian drugmaker Ablynx has posted 2016 half-yearly financial results showing its revenue and grant income rose by 39% compared to 2015’s first six months. 25 August 2016
Generics
Hikma Pharmaceuticals saw its profits drop by 14% in the first half of 2016 compared to last year, but the Jordan-based drugmaker has reiterated its full year revenue guidance. 24 August 2016
Generics
Canada's battered drugmaker Valeant Pharmaceuticals International has had some good news in the shape of lender consent for an amendment to its credit facility, but it comes in the midst of accusations from its former shareholder T Rowe Price. 22 August 2016
Pharmaceutical
The market for respiratory drugs will grow from its 2015 size of $28.1 billion to $46.6 billion by 2022 at a compound annual growth rate (CAGR) of 7.5%, according to business intelligence provider GBI Research. 18 August 2016
Pharmaceutical
In our weekly expert view piece, Ed Corbett, engagement manager at specialist management consultancy firm Novasecta, explores the different routes British pharma giant GSK might take to ensure its next wave of growth. 18 August 2016
Pharmaceutical
Canada-based drugmaker Valeant Pharmaceuticals' share price soared by more than a quarter on Tuesday – despite missing analyst predictions in its quarterly results. 10 August 2016
Pharmaceutical
It was a grim Monday morning for Ireland-incorporated company Allergan as its share price slid by nearly 3% in early trading after posting quarterly results which did not deliver the revenue returns which analysts expected. 8 August 2016
Pharmaceutical
More than 9% was wiped off the value of Novo Nordisk’s share price on Friday as the Danish diabetes giant reduced its sales and profit estimates for the year. 5 August 2016
Generics
Bosses at Teva Pharmaceutical Industries remain confident in its ability to deliver multi-year growth despite a slight dip in sales in its generics business in this year’s second quarter compared to the same period of 2015. 4 August 2016
Pharmaceutical
German science and technology company Merck KGaA (MRK: DE) reported an 18.2% increase in net sales to 3.8 billion euros ($4.2 billion) in its second quarter results. 4 August 2016
Pharmaceutical
Shares in Anglo-Irish drugmaker Shire Pharmaceuticals rose 2.8% after the company upgraded its profit forecasts on the back of positive second quarter results. 2 August 2016
Pharmaceutical
US pharma giant Pfizer beat earnings expectations with its 2nd-qtr 2016 financial results, but markets responded negatively as its share price dropped by nearly 2.5% to $36.39 in Tuesday morning’s trading. 2 August 2016
Biotechnology
Aptevo Therapeutics has completed its separation from US biotech Emergent BioSolutions to become an independent, publicly traded corporation. 2 August 2016
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze